The Venture Codex Logo

The Venture Codex

AZ Venture Development Corporation

2303 N 44th St., Ste. 14-1203, Phoenix, AZ, 85008, United States

Overview

At AVC, we invest in early-stage technology startups and funds across enterprise, software, consumer, climate-tech, and bio/health tech—all while helping catalyze access to equity cAZ Venture Capital Inc. is a venture capital fund that invests in pre-seed through Series B rounds of funding in early-stage Arizona startups and early growth companies that solve important customer problems. We invest in a broad range of industries, including software, IT hardware, health tech—including medical devices, diagnostics, and therapeutics—and green tech. AVC is committed to investing in founders from traditionally underserved communities and making Arizona a great place to start a company, regardless of background.

Total investments
6
Lead investments
1
Investments · 12mo
2
Active investors
1
Visit website

Investment portfolio

  • Prickly Pear Health

    Participated · Seed · Mar 2026

    Prickly Pear Health offers a NextGen digital platform that combines voice AI, behavioral analytics, and wearable data to deliver personalized insights about how hormonal fluctuations affect cognitive and emotional health. The platform targets symptoms such as brain fog, stress, and memory changes across pregnancy, postpartum, irregular cycles, perimenopause, and menopause. Since launching in 2024, the company has surpassed 2,000 active users in its current phase and is developing toward a broader public launch. With the expanded pre-seed funding, Prickly Pear plans to accelerate user growth and begin expanding deployments with mental health practices starting in Arizona. The company positions itself to build a new category within digital brain health by integrating hormonal science with personalized technology. Financially, it has raised more than $600,000 in pre-seed capital with participation from Emmeline Ventures, Bayless Ventures, and AZ Venture Capital Inc.

  • Lenoss Medical

    Participated · Equity · Mar 2026

    Lenoss Medical is a growth-stage biomedical company headquartered in Providence, RI, focused on biological solutions for physiological repair of skeletal defects. Its flagship platform, OsteoPearl®, is an implant and surgical instrument system designed to enable physicians to place natural bone where additional bone is required in spinal vertebral augmentation procedures. The company reported record sales in the fourth quarter and year-over-year surgical procedure growth of nearly 150%, demonstrating accelerating clinical adoption. Management plans to use new capital to expand commercial coverage by hiring regional sales leadership, to increase clinical data generation, and to scale operations and marketing to support further adoption. The company is led by an experienced team of MedTech professionals and counts multiple venture investors and angels among its backers.

  • ALTR

    Participated · Seed · Jul 2025

    ALTR develops a proprietary membrane-based “Flavor-First” alcohol-removal technology engineered to extract ethanol at a molecular level without disturbing a wine’s flavor, structure, or mouthfeel. The system is positioned as a non-destructive, low-environmental-impact alternative to traditional dealcoholization techniques, allowing wineries to produce premium low-alcohol wines that honor traditional craft. Led by founder and CEO Richard Schatzberger, the company integrates membrane scientists with renowned winemakers to balance technical precision and sensory excellence. ALTR is initially targeting collaborations with leading global wineries and newly emerging brands, aiming to set an industry standard for mindful-drinking products. The firm also emphasizes sustainability, noting the process addresses climate-driven rises in grape sugar—and thus finished alcohol—while meeting shifting consumer demographics seeking lower-ABV options. With a fresh $5 million seed round, ALTR plans to accelerate product commercialization and scale industry partnerships. Although the company has not released revenue or user metrics, the capital injection provides its first disclosed funding and positions the team to usher in what it calls the “Next Era of Wine.”

  • Schola

    Participated · Series A · Jan 2023

    Schola is a software company that provides an online platform for families and schools to improve PK-12 education outcomes. The platform helps families discover, connect with, and enroll in ideal school settings and helps schools source, enroll, and engage prospective families. Led by CEO Jaime Martinez and based in Phoenix, Arizona, the company intends to use the new funds to continue nationwide expansion. Schola reports triple-digit annual recurring revenue growth. The company has already surpassed 100K students searching for the most suitable school on its platform to improve educational outcomes across the United States.

  • DashLX

    Participated · Seed · Jan 2023

    DashLX provides Lived Experience (LX) data by leveraging wearable technology data with user permission to translate physical experiences into the digital world. Its solutions emphasize hyper-personalization and authentic community-building to help brands improve sales, marketing, R&D and product development. The company is led by CEO and co-founder Adam Stepanovic. DashLX raised $2.5M in seed funding. It intends to use the funds to accelerate growth and expand operations. The company is based in Flagstaff, AZ.

Team

  • James Goulka

    Chairman & Managing Director

    LinkedIn